Ashland Global (ASH:ASX) Investor Relations Material

Overview

Ashland Inc., a global provider of additives and specialty ingredients, has reported its operations across four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Its Life Sciences segment boasts a range of pharmaceutical solutions, including controlled-release polymers, tablet coatings, and solubilizers. Additionally, Ashland Inc. offers custom formulations, particle engineering, and toll processing solutions. The Personal Care segment provides nature-based, biodegradable, and performance ingredients for various uses, such as toothpastes, mouth washes, and surface wetting agents. The Specialty Additives segment offers foam control agents, surfactants, and pH neutralizers for a range of industrial markets, such as environmental filters, plasma display panels, and solar cells. The Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Founded in 1924, Ashland Inc. is headquartered in Wilmington, Delaware, and serves consumers across multiple industries, including pharmaceuticals, personal care, food and beverage, and construction. The company was formerly known as Ashland Global Holdings Inc. and officially changed its name to Ashland Inc. in August 2022.

Frequently Asked Questions

What is Ashland Global's ticker?

Ashland Global's ticker is ASH

What exchange is Ashland Global traded on?

The company's shares trade on the ASX stock exchange

Where are Ashland Global's headquarters?

They are based in Sydney, Australia

How many employees does Ashland Global have?

There are 201-500 employees working at Ashland Global

What is Ashland Global's website?

It is ashland.com

What type of sector is Ashland Global?

Ashland Global is in the Industrial Goods sector